Glenmark Pharmaceuticals Ltd 532296
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- INR 1,010.60
- Day Range
- INR 987.45–1,017.20
- 52-Week Range
- INR 581.20–1,098.00
- Bid/Ask
- INR 0.00 / INR 0.00
- Market Cap
- INR 282.89 Bil
- Volume/Avg
- 16,003 / 41,771
Key Statistics
- Price/Earnings (Normalized)
- 75.04
- Price/Sales
- 2.39
- Dividend Yield (Trailing)
- 0.24%
- Dividend Yield (Forward)
- 0.24%
- Total Yield
- 0.25%
Company Profile
Glenmark Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company's research and development activity is focused on generating intellectual property assets that will help address unmet medical needs. Glenmark's product categories include novel molecular entities, formulations, and API products. The company considers merger and acquisition investment to be a potential component for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 11,719
- Website
- https://www.glenmarkpharma.com
Comparables
Valuation
|
Metric
|
532296
|
543322
|
524348
|
|---|---|---|---|
Price/Earnings (Normalized) | 75.04 | 21.21 | 25.63 |
Price/Book Value | 3.06 | 4.28 | 3.40 |
Price/Sales | 2.39 | 4.38 | 1.72 |
Price/Cash Flow | 16.07 | 18.30 | 19.39 |
Price/Earnings
532296
543322
524348
Financial Strength
|
Metric
|
532296
|
543322
|
524348
|
|---|---|---|---|
Quick Ratio | 0.78 | 2.64 | 0.91 |
Current Ratio | 1.93 | 4.37 | 1.66 |
Interest Coverage | −0.21 | 409.34 | 8.03 |
Quick Ratio
532296
543322
524348
Profitability
|
Metric
|
532296
|
543322
|
524348
|
|---|---|---|---|
Return on Assets (Normalized) | — | 16.82% | 7.10% |
Return on Equity (Normalized) | — | 20.87% | 13.89% |
Return on Invested Capital (Normalized) | — | 20.73% | 10.74% |
Return on Assets
532296
543322
524348
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Gvfkdpls | Fmhy | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Tzbmvrsnkk | Jghrhgp | $74.3 Bil | |
HLN
| Haleon PLC ADR | Njsnmgyc | Gycp | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Ncjlpnn | Mhqvw | $18.3 Bil | |
VTRS
| Viatris Inc | Tpsfsyqq | Zxvsj | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Fyzzhrt | Mrfx | $11.7 Bil | |
CTLT
| Catalent Inc | Jxlgknxn | Rkqpcyk | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Lbfttkwz | Hmqj | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Yhwdpbz | Lxqh | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Hxsmvjcyz | Cxtbp | $3.5 Bil |